TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇮🇳ANUHPHR

ANUHPHR

NSE
₹80.45
▲ ₹4.30 (+5.6%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 03 Jul 2026
H ₹86.81L ₹67.00+3.0%
₹86.81₹82.85₹78.89₹74.92₹70.96₹67₹80.45
RSI (14)
Intraday · 15-minStrong sell-45RSI 45DowntrendMACD Bearishfor day-trading context — not advice

Technical signal

Buy+30
RSI (14)55
oversold 30overbought 70
Trend
Sideways
MACD
Bullish
Bollinger
Within bands
vs 20-day
above
vs 50-day
above
vs 200-day
above
Support
₹75.12
Resistance
₹83.90
  • Price is above its 50-day average (medium-term uptrend).
  • Price is above its 200-day average (long-term uptrend).

Signal backtest · 2025-09-29 → 2026-07-03

Strategy return
-18.4%
Buy & hold
-2.9%
Trades
8
Win rate
13%

₹1,00,000.00 invested would be worth ₹81,580.05 (-18.4%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Anuh Pharma Limited· Drug Manufacturers - Specialty & Generic

source: yahoo

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Mumbai, India
www.anuhpharma.com ↗

Fundamentals

source: yahoo
Market cap
₹806.3Cr
P/E
19.6
P/B
2.3
EPS
₹4.10
Div yield
1.9%
Profit margin
5.3%
ROE
12.1%
Debt / Equity
0.00
Beta
0.43
52-week range
₹67.00 – ₹114.84
52-week low · ₹67.0028% of rangehigh · ₹114.84

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:— Neutral1↑ · 1↓ · 6–
  • Tennessee deputy spent seized drug money on Apple gear for his family — now he owes $339K in pension clawbacks— Neutral
    Moneywise · 04 Jul 2026
  • Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”— Neutral
    Insider Monkey · 04 Jul 2026
  • Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”▲ Positive
    Insider Monkey · 04 Jul 2026
  • Jim Cramer Says He Would Avoid Blue Owl and Prefers Blackstone

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

— Neutral
Insider Monkey · 04 Jul 2026
  • Jim Cramer on Palantir: “This Is the Fastest Grower of the Stocks I Follow, and It’s Been Crushed”— Neutral
    Insider Monkey · 04 Jul 2026
  • EPR's CFO Sold Shares at a Premium — Here's the Bet Behind the Stock— Neutral
    Motley Fool · 04 Jul 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.